ASND insider transactions
Ascendis Pharma A/S (ASND) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ASND
- EVP & Chief Financial Officer Smith Scott Thomas bought $21,900 worth of Ordinary Shares (100 units at $219.00), increasing direct ownership by 2% to 4,367 units (SEC Form 4)4 - Ascendis Pharma A/S (0001612042) (Issuer)
- Director Bienaime Jean Jacques bought $111,562 worth of Ordinary Shares (500 units at $223.12), increasing direct ownership by 125% to 900 units (SEC Form 4)4 - Ascendis Pharma A/S (0001612042) (Issuer)
- EVP & Chief Financial Officer Smith Scott Thomas bought $55,830 worth of Ordinary Shares (250 units at $223.32), increasing direct ownership by 6% to 4,267 units (SEC Form 4)4 - Ascendis Pharma A/S (0001612042) (Issuer)
- Amendment: New insider Smith Scott Thomas claimed ownership of 4,017 units of Ordinary Shares (SEC Form 3)3/A - Ascendis Pharma A/S (0001612042) (Issuer)
- Director Bienaime Jean Jacques bought $95,120 worth of Ordinary Shares (400 units at $237.80) (SEC Form 4)4 - Ascendis Pharma A/S (0001612042) (Issuer)
- Officer Jensen Flemming Steen sold $4,641,021 worth of Ordinary Shares (19,460 units at $238.49), closing all direct ownership in the company (SEC Form 4)4 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Bienaime Jean Jacques3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Fairey William3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Imani Siham3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Smith Scott Thomas3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Jensen Michael Wolff3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Bodenhoff Mads3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Pedersen Anni Lotte Kirstine Sonderbjerg3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Morrison Lisa3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Holtug Lars3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Sprogoe Kennett3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Mikkelsen Jan Moller3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Wu Jay Donovan3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Jensen Flemming Steen3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Cha Albert3 - Ascendis Pharma A/S (0001612042) (Issuer)
- SEC Form 3 filed by new insider Shu Aimee3 - Ascendis Pharma A/S (0001612042) (Issuer)